Regencell Bioscience Holdings Ltd (RGC)

Regencell Bioscience Holdings Ltd (RGC) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $4.8B; returns 1 day -21.8%, 1 week -20.0%, 1 year -52.1%.

Regencell Bioscience Holdings Ltd. (RGC) is an early-stage bioscience company based in Hong Kong, primarily focused on the research, development, and eventual commercialization of proprietary Traditional Chinese Medicine (TCM) formulas.

Groups RGC belongs to

• Clinical Stage Biotech
• Biotechnology
• Healthcare
• Hong Kong
• CNS Disorders
• Neurological Disorders
• Neuroscience
• R&D

RGC financial model: income statement, cash flow and balance sheet